Cancer Research in Switzerland - Krebsliga Schweiz
Cancer Research in Switzerland - Krebsliga Schweiz
Cancer Research in Switzerland - Krebsliga Schweiz
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
24<br />
<strong>Research</strong> awards:<br />
Besides support<strong>in</strong>g research through fund<strong>in</strong>g<br />
projects, bursaries, and organizations, the Swiss<br />
<strong>Cancer</strong> League regularly gives the Robert Wenner<br />
Award for outstand<strong>in</strong>g research work. In addition,<br />
each year the Scientific Office of the Swiss <strong>Cancer</strong><br />
League organizes the call for research grant<br />
applications and the evaluation of proposals submitted<br />
for the SWISS BRIDGE AWARD.<br />
With the award<strong>in</strong>g of research prizes, the recipients<br />
are recognized for their excellent work <strong>in</strong> cancer research.<br />
For the researchers, this recognition means<br />
both honour for their previous achievements and<br />
<strong>in</strong>centive for future research efforts. As the greatest<br />
part of the award money must be <strong>in</strong>vested <strong>in</strong> cancer<br />
research, research awards allow the recipients to<br />
cont<strong>in</strong>ue their work or to <strong>in</strong>itiate new projects. For<br />
the Swiss <strong>Cancer</strong> League the award<strong>in</strong>g of research<br />
prizes is also a way to <strong>in</strong>form the public about outstand<strong>in</strong>g<br />
<strong>in</strong>dustry-<strong>in</strong>dependent cancer research.<br />
Robert Wenner Award<br />
Robert Wenner, a gynaecologist <strong>in</strong> Basel who died<br />
<strong>in</strong> 1979, endowed the Robert Wenner Award to<br />
support cancer researchers under the age of 45.<br />
The prize was awarded for the first time <strong>in</strong> 1985.<br />
The award w<strong>in</strong>ners receive CHF 100,000, with<br />
CHF 80,000 earmarked for an ongo<strong>in</strong>g project and<br />
CHF 20,000 as discretionary funds. In 2010 the<br />
Robert Wenner Award was given to Prof. Dr. Melody<br />
Swartz at the Swiss Federal Institute of Technology<br />
Lausanne (EPFL) for her excellent work <strong>in</strong> basic research<br />
on tumour metastasis. No prize was awarded<br />
<strong>in</strong> 2009.<br />
Honour<strong>in</strong>g outstand<strong>in</strong>g cancer researchers<br />
Interdiscipl<strong>in</strong>ary cancer researcher<br />
Melody Swartz is a bioeng<strong>in</strong>eer who <strong>in</strong>tegrates different<br />
modern scientific discipl<strong>in</strong>es <strong>in</strong> her research.<br />
Together with her team she comb<strong>in</strong>es cell biology,<br />
biochemistry, physiology, bio<strong>in</strong>formatics, and eng<strong>in</strong>eer<strong>in</strong>g<br />
to study cancer. Her <strong>in</strong>terest centres on the<br />
lymphatic system and, specifically, on how tumour<br />
cells behave <strong>in</strong> the lymphatic system. The lymphatic<br />
system, which works with the circulatory system,<br />
is made up of lymph nodes and lymphatic vessels <strong>in</strong><br />
which lymph fluid circulates. The lymphatic system<br />
transports pathogens to the lymph nodes, where<br />
antibodies are produced and an immune response is<br />
mounted. The immune response thus depends on the<br />
lymphatic system.<br />
Cunn<strong>in</strong>g cancer cells<br />
It is known that cancer cells also utilize lymphatic<br />
vessels to spread through the body and form metastases<br />
at new sites. However, this process is still largely<br />
unknown. Among other th<strong>in</strong>gs, Swartz is study<strong>in</strong>g<br />
how cancer cells move <strong>in</strong>to the lymph vessels. It appears<br />
that tumours are able to stimulate the growth<br />
of the lymph vessels so that cancer cells can <strong>in</strong>vade<br />
them. Also, the lymph vessels appear to actively<br />
support the tumour cells <strong>in</strong> this process. The immune<br />
system is fooled, and the cancer cells evade the<br />
immune defence.